Ju, H., Hu, J., Wu, Y., Xia, R., Shi, C., Ren, G., He, Y. (2025). Cetuximab plus dalpiciclib in patients with HPV-negative, anti-PD-1-resistant recurrent or metastatic head and neck squamous cell carcinoma.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.6026